Legal status · United States
Is LL-37 legal in the United States?
No. LL-37 is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.
LL-37 in the United States at a glance
| Classification | Not approved; research use only |
|---|---|
| FDA approval status | Not FDA-approved; research peptide |
| Evidence level | Preliminary (research strength: Preliminary) |
| Reviewed | Sep 2026 |
Classification and note come from the LL-37 profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing LL-37 is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What LL-37 is
The main human cathelicidin antimicrobial peptide, central to innate immunity and wound healing, with a complex double-edged role in disease.
LL-37 is the active form of the only human cathelicidin, a key part of innate immune defense. It kills microbes directly, supports wound healing, and shapes immune responses.
Mechanism: Disrupts microbial membranes and modulates immune cell activity, wound repair, and inflammation.
Regulatory history: Not FDA-approved; research peptide
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for LL-37 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
LL-37 in other countries
Frequently asked questions
Is LL-37 legal in the United States?
No. LL-37 is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.
Can I buy LL-37 in the United States?
No approved product exists to buy. In the United States LL-37 is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is LL-37 FDA approved?
No. FDA status: Not FDA-approved; research peptide. Current US classification: "Not approved; research use only". Evidence level: Preliminary.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for LL-37 live on its compound profile.
LL-37 profileThis page is general information about the regulatory status of LL-37 in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.